Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
KEROS THERAPEUTICS INC
About KROS
Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing novel therapeutics to treat a range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (TGF-B), family of proteins. Its lead product candidate, elritercept (KER-065), is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, and in patients with myelofibrosis. KER-065 is designed to act as a ligand trap and inhibit the biological effects of myostatin and activin A. Its lead product candidate, rinvatercept, is being developed for the treatment of neuromuscular diseases. Elritercept is designed to raise red blood cell and platelet production by inhibiting the signaling of a subset of the TGF-B family of proteins to promote hematopoiesis.
Find out what a historical investment in KEROS THERAPEUTICS INC would be worth today using our KROS stock calculator.
Market Capitalisation
$207.81M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
572.2K
High today
$10.83
Low today
$10.30
Open price
$10.76
52-week high
$22.55
52-week low
$10.32
Ready to start your investing journey with Stake?
Open an accountHow do I buy KROS shares in Australia?
Buying KROS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in KEROS THERAPEUTICS INC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in KROS
What is the ticker symbol of KEROS THERAPEUTICS INC?
The ticker symbol for KEROS THERAPEUTICS INC is KROS.
How much is one share of KROS?
One share of KROS is valued at $10.35 as of 16 May 2026.
What is the market capitalisation of KEROS THERAPEUTICS INC KROS?
As of 16 May 2026 KEROS THERAPEUTICS INC has a market cap of $207.81M.
What is the 52-week high for KEROS THERAPEUTICS INC stock?
The KEROS THERAPEUTICS INC 52-week high stock price is $22.55.
What is the 52-week low for KEROS THERAPEUTICS INC stock?
The KEROS THERAPEUTICS INC 52-week low stock price is $10.32.
Can I buy KROS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy KROS shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in KROS on Stake
- Buy KROS from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of KROS from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
KROS related stocks